Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. - Wikidata - wikimedia - TriplyDB

Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

http://www.wikidata.org/entity/Q33431547

about

Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging TAFRO Syndrome Associated with EBV and Successful Triple Therapy Treatment: Case Report and Review of the Literature.Magnetic resonance imaging of bone marrow for TAFRO syndrome.TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome Castleman's disease with TAFRO syndrome: a case report from Syria Anasarca, Fever, Thrombocytopenia, Organomegaly, and Multiorgan Failure in a 24-Year-Old Pregnant Woman.Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome.Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease.Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure.Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan.Castleman disease: delineating the spectrum.Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.Interleukin-6 in idiopathic multicentric Castleman's disease after long-term tocilizumab.A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.Nephrotic Syndrome with Thrombocytopenia, Lymphadenopathy, Systemic Inflammation, and Splenomegaly.Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman's disease.TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements.Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.

P2860

Q32182008-5868F165-338F-4691-BE2B-226A1AB1449B Q33436275-6C72055A-840F-4D8E-B9A1-C3DCBAE43067 Q33436635-08C04B12-9F6A-4245-AC1B-234EC333D220 Q33438812-569450EA-CFB7-42CE-965F-751150C5891B Q33439399-4F73D4A1-6B6D-4D04-B31D-2424A9995786 Q33441886-44C54C64-05AD-4300-A7FA-AE8A8CC9BFA8 Q33442420-A4B17332-4458-4A27-B79C-969867DB116C Q33443714-F589FA56-1050-4477-8FB6-4B2E4772587B Q40042816-4395B23C-70D8-4ADF-BF3B-EE9234753A05 Q40044420-073FAB72-5A24-4179-895C-8A8A12C0FDA0 Q41678341-BC8F1A54-B9F4-4D43-967E-B520CD800910 Q41927889-D320BD83-F694-4215-92E4-E78BCDF6B45A Q41928746-FAA09391-6FCF-4B44-B484-6FB1565FA053 Q42364525-1F8F4238-BD8B-4BAB-89F6-B4368FDCC32D Q47097223-D71DC125-4739-4A70-B1D3-09EB36D35035 Q47584137-432A516C-F8B9-414B-997C-85138E87391C Q47669677-DEF53FB7-0655-4545-A073-E63C1CE99866 Q47780672-4C66574C-AB29-403E-8BA4-5B098687F565 Q48294900-2B590D83-68EE-443E-B6AB-CB4EDDC97CE6 Q49487524-532BF604-8E4D-4F69-8831-DD699ACE0809 Q49723291-84D80052-4A97-4019-A329-6C17D6C67FAC Q50101690-9BE5A13F-B2A1-4457-B067-3A9475123FDD Q50238394-5FD419B5-EB46-4D35-B439-1790E2A22AC3 Q52720139-8BE9EF1A-11CF-4F61-A9E6-277D7E76D428 Q54594948-F112BD51-1C16-4427-B86B-48CC90637E73 Q54684652-51567648-3D07-4AA6-BA87-2C47F5A673D6 Q54988723-588EBC46-4286-4BB5-86BE-4D5D67F9A49D Q55024047-F81DE985-816E-471D-B408-566737FF767F Q55265167-0A09FF9B-3685-48C7-92B0-75432838F636 Q55407039-E8909FE1-5286-4EF5-AB95-B1F08744B3EE

P2860

Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

http://www.wikidata.org/entity/Q33431547

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Proposed diagnostic criteria, ...... TAFRO syndrome, 2015 version.

@ast

Proposed diagnostic criteria, ...... TAFRO syndrome, 2015 version.

@en

type

label

Proposed diagnostic criteria, ...... TAFRO syndrome, 2015 version.

@ast

Proposed diagnostic criteria, ...... TAFRO syndrome, 2015 version.

@en

prefLabel

Proposed diagnostic criteria, ...... TAFRO syndrome, 2015 version.

@ast

Proposed diagnostic criteria, ...... TAFRO syndrome, 2015 version.

@en

P1433

Q33431547-4553EBAB-2990-4CDD-A3B1-25188EE2942F

P1476

Q33431547-6EB4B838-E939-48C4-A59D-9A7D79334F22

P2093

Q33431547-0409C7DB-4D67-4CB4-A42F-9BD95E9C9223

Q33431547-1AF27AEA-F4AC-4308-8B64-E9171CB9C74B

Q33431547-24339EF5-1E30-4552-8734-32E5D4E06272

Q33431547-3D414AC3-3F04-45F5-88B5-77E4AA6C1F44

Q33431547-54FF83D5-0A8D-4D57-8D9A-338A6D108C07

Q33431547-5DF215C7-2118-4335-8C66-49AC3441BF19

Q33431547-627B4CEC-0A80-4AD5-B8CF-007A76B0EF0B

Q33431547-698D2D78-366F-4D33-89DB-4D21E9106BA6

Q33431547-6BA54A6C-5A74-4345-BAD1-EB2779DC1E1D

Q33431547-7708ECC1-F738-4D4F-94AE-7A5EEC6CBA37

P2860

Q33431547-369EA681-4EE4-4514-868A-C36F7627B822

Q33431547-36A1C05D-CCC2-408B-8C78-2589C156E878

Q33431547-53236443-E0B8-42DF-8DD7-9883A72C89F6

Q33431547-673CBEE8-D43F-4C28-B981-ED2FDDC9D247

Q33431547-6CEBEAEB-BFC5-4FBE-BB5C-E320004CF7EA

Q33431547-7506981D-EE6F-4BDE-917C-C5CF841DEAF1

Q33431547-8A0BAC96-D7DC-4A81-A713-E1CCFCFBD0A7

Q33431547-B10EC6E8-418F-498E-8E8E-AF145DBFDFCD

Q33431547-B4213E19-8E24-4DDD-A897-F735EB03F1BB

Q33431547-CDFA622A-FAF4-4C3B-8BEA-14EA37E231D4

P2888

Q33431547-51E56E56-DE7F-4AD5-8B2C-3D0252095019

P304

Q33431547-409098D1-D93A-4FD7-94E9-FAA219CE8017

P31

Q33431547-63ADF3F4-0E64-448C-950B-DF484D7F82DA

P356

Q33431547-DDADD60E-EAC9-45D7-81AF-A9468D2D0B6B

P433

Q33431547-A1C2AFEC-D99C-44E9-843A-37E27CD6BFD3

P478

Q33431547-729CCBE4-3BF0-49CC-AE86-5C03E93AA428

P577

Q33431547-FBC4D50C-8CF3-4636-8626-A199F9FDE086

P6179

Q33431547-75378087-F5C4-4164-B359-D4721EBD5495

P698

Q33431547-9411C6DF-9186-49ED-8F42-7845CBB2EFA0

P356

S12185-016-1979-1

P1433

International Journal of Hematology

P1476

Proposed diagnostic criteria, ...... TAFRO syndrome, 2015 version.

@en

P2093

Akihito Momoi

http://www.w3.org/2001/XMLSchema#string

Haruka Kawanami

http://www.w3.org/2001/XMLSchema#string

Hidekazu Takahashi

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kawabata

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yamamoto

http://www.w3.org/2001/XMLSchema#string

Jun Murakami

http://www.w3.org/2001/XMLSchema#string

Katsuhiro Miura

http://www.w3.org/2001/XMLSchema#string

Kazue Takai

http://www.w3.org/2001/XMLSchema#string

Kenji Nara

http://www.w3.org/2001/XMLSchema#string

Makoto Ide

http://www.w3.org/2001/XMLSchema#string

P2860

Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.

Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly : a clinical report of five cases.

Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute.

Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?

Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.

Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.

The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.

The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases.

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a s

P2888

s12185-016-1979-1

P304

686-692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-016-1979-1

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030406860

http://www.w3.org/2001/XMLSchema#string

P698

27084250

http://www.w3.org/2001/XMLSchema#string